Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
502
502 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- AR-17043Phase 21 trial
Alcon Research · Open Angle Glaucoma, Ocular Hypertension
- ASP2246Phase 21 trial
Astellas · Chronic Ischemic Stroke
- AT673Phase 21 trial
Antag Therapeutics · Adults With Overweight/Obesity and Type 2 Diabetes
- ATR 1072Phase 21 trial
Atrium Therapeutics · Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic
- AUP1602-CPhase 21 trial
Aurealis Oy · Diabetic Foot Ulcer
- AZD3427Phase 21 trial
AstraZeneca · Pulmonary Hypertension (World Health Organization Group 2), Heart Failure
- AZD5462Phase 21 trial
AstraZeneca · Chronic Heart Failure
- B2065Phase 21 trial
Tasly Pharmaceutical Group Co., Ltd · Acute Ischemic Stroke
- BAY 3670549Phase 21 trial
Bayer · Atrial Fibrillation
- BAY3018250Phase 21 trial
Bayer · Thrombolysis, Symptomatic Proximal Deep Vein Thrombosis
- BB-031DTRI-031Phase 21 trial
Basking Biosciences, Inc. · Acute Ischemic Stroke
- BB-101Phase 21 trial
Blue Blood Biotech Corp. · Diabetic Foot Ulcer
- BEBT-701Phase 21 trial
BeBetter Med Inc · Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol
- BGM1812plcaeboPhase 21 trial
BrightGene Bio-Medical Technology Co., Ltd. · Overweight or Obese Participants Without Diabetes
- BI 3034701Phase 21 trial
Boehringer Ingelheim · Obesity, Overweight
- BI 3812465Phase 21 trial
Boehringer Ingelheim · Diabetic Macular Edema
- BI 764524Phase 21 trial
Boehringer Ingelheim · Diabetic Retinopathy
- BIO101Phase 21 trial
Biophytis · Muscle Wasting, Obesity & Overweight, Obesity
- BMS-986435MYK-224Phase 21 trial
Bristol Myers Squibb · Heart Failure
- BR1400-1Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-2Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-3Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-4Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-5Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-APhase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-BPhase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-CPhase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BW-00112Phase 21 trial
Shanghai Argo Biopharmaceutical Co., Ltd. · Mixed Dyslipidemia
- CD25Phase 21 trial
PolTREG S.A. · Presymptomatic Diabetes Type 1 (Stage 1), Diabetes Mellitus, Type I, Diabetes Mellitus, Type 1
- CNP-103Phase 21 trial
COUR Pharmaceutical Development Company, Inc. · Type 1 Diabetes Mellitus, T1D, T1DM
- COR-1167Phase 21 trial
Corteria Pharmaceuticals · Worsening Heart Failure
- CPX101Phase 21 trial
Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. · Overweight and Obesity
- CTX340Phase 21 trial
CRISPR Therapeutics AG · Hypertension
- CU01-1001Phase 21 trial
Curacle Co., Ltd. · Diabetic Nephropathies
- CU06-1004Phase 21 trial
Curacle Co., Ltd. · DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)
- DA-2811Phase 21 trial
Dong-A ST Co., Ltd. · Diabete Mellitus
- DA-2811-CPhase 21 trial
Dong-A ST Co., Ltd. · Diabete Mellitus
- DIAG723Phase 21 trial
Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension
- DNV001Phase 21 trial
Hangzhou Dinovate Biotech Co., Ltd · Primary Hypercholesterolemia
- EDG-15400Phase 21 trial
Edgewise Therapeutics, Inc. · Heart Failure With Preserved Ejection Fraction
- EDG-7500Phase 21 trial
Edgewise Therapeutics, Inc. · Hypertrophic Cardiomyopathy
- EDIT-401Phase 21 trial
Editas Medicine, Inc. · Heterozygous Familial Hypercholesterolemia (HeFH)
- ELU42Phase 21 trial
Eluciderm Inc · Diabetic Foot Ulcer, Wagner Grade 1 - 2, Chronic Wound
- ENN0403Phase 21 trial
EnnovaBio · Diabetic Macular Edema (DME)
- ERX1000Phase 21 trial
ERX Pharmaceuticals · Obesity & Overweight
- GL0034Phase 21 trial
Sun Pharmaceutical Industries Limited · Type II Diabetes Mellitus
- GZR101-80Phase 21 trial
Gan & Lee Pharmaceuticals. · Type 2 Diabetes (T2DM)
- GZR102Phase 21 trial
Gan & Lee Pharmaceuticals. · Type 2 Diabetes Mellitus (T2DM)
- HBI-3000sulcardine sulfatePhase 21 trial
HUYABIO International, LLC. · Atrial Fibrillation
- HD-6277Phase 21 trial
Hyundai Pharm · Type 2 Diabetes Mellitus (T2DM)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.